vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Root, Inc. (ROOT). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $397.0M, roughly 1.2× Root, Inc.). On growth, Root, Inc. posted the faster year-over-year revenue change (21.5% vs -1.7%). Over the past eight quarters, Root, Inc.'s revenue compounded faster (24.8% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Root Insurance Company is an online car insurance company operating in the United States.
MD vs ROOT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $397.0M |
| Net Profit | $33.7M | — |
| Gross Margin | — | — |
| Operating Margin | 9.9% | 2.6% |
| Net Margin | 6.8% | — |
| Revenue YoY | -1.7% | 21.5% |
| Net Profit YoY | 10.5% | — |
| EPS (diluted) | $0.40 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $397.0M | ||
| Q3 25 | $492.9M | $387.8M | ||
| Q2 25 | $468.8M | $382.9M | ||
| Q1 25 | $458.4M | $349.4M | ||
| Q4 24 | $502.4M | $326.7M | ||
| Q3 24 | $511.2M | $305.7M | ||
| Q2 24 | $504.3M | $289.2M | ||
| Q1 24 | $495.1M | $254.9M |
| Q4 25 | $33.7M | — | ||
| Q3 25 | $71.7M | $-5.4M | ||
| Q2 25 | $39.3M | $22.0M | ||
| Q1 25 | $20.7M | $18.4M | ||
| Q4 24 | $30.5M | — | ||
| Q3 24 | $19.4M | $22.8M | ||
| Q2 24 | $-153.0M | $-7.8M | ||
| Q1 24 | $4.0M | $-6.2M |
| Q4 25 | 9.9% | 2.6% | ||
| Q3 25 | 13.8% | 0.1% | ||
| Q2 25 | 12.8% | 7.1% | ||
| Q1 25 | 7.0% | 6.8% | ||
| Q4 24 | 7.8% | 10.7% | ||
| Q3 24 | 6.6% | 11.3% | ||
| Q2 24 | -31.3% | 1.3% | ||
| Q1 24 | 3.2% | 2.1% |
| Q4 25 | 6.8% | — | ||
| Q3 25 | 14.5% | -1.4% | ||
| Q2 25 | 8.4% | 5.7% | ||
| Q1 25 | 4.5% | 5.3% | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 3.8% | 7.5% | ||
| Q2 24 | -30.3% | -2.7% | ||
| Q1 24 | 0.8% | -2.4% |
| Q4 25 | $0.40 | $0.35 | ||
| Q3 25 | $0.84 | $-0.35 | ||
| Q2 25 | $0.46 | $1.29 | ||
| Q1 25 | $0.24 | $1.07 | ||
| Q4 24 | $0.37 | $1.42 | ||
| Q3 24 | $0.23 | $1.35 | ||
| Q2 24 | $-1.84 | $-0.52 | ||
| Q1 24 | $0.05 | $-0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $669.3M |
| Total DebtLower is stronger | $570.5M | $200.3M |
| Stockholders' EquityBook value | $865.9M | $284.3M |
| Total Assets | $2.2B | $1.7B |
| Debt / EquityLower = less leverage | 0.66× | 0.70× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $669.3M | ||
| Q3 25 | $340.1M | $653.3M | ||
| Q2 25 | $224.7M | $641.4M | ||
| Q1 25 | $99.0M | $609.4M | ||
| Q4 24 | $229.9M | $599.3M | ||
| Q3 24 | $103.8M | $674.8M | ||
| Q2 24 | $19.4M | $667.2M | ||
| Q1 24 | $8.0M | $640.5M |
| Q4 25 | $570.5M | $200.3M | ||
| Q3 25 | $577.2M | $200.4M | ||
| Q2 25 | $583.9M | $200.1M | ||
| Q1 25 | $590.5M | $200.0M | ||
| Q4 24 | $597.1M | $200.1M | ||
| Q3 24 | — | $300.9M | ||
| Q2 24 | — | $300.1M | ||
| Q1 24 | — | $299.3M |
| Q4 25 | $865.9M | $284.3M | ||
| Q3 25 | $890.7M | $265.0M | ||
| Q2 25 | $833.8M | $244.5M | ||
| Q1 25 | $789.2M | $228.7M | ||
| Q4 24 | $764.9M | $203.7M | ||
| Q3 24 | $732.5M | $181.9M | ||
| Q2 24 | $706.5M | $151.3M | ||
| Q1 24 | $856.2M | $165.7M |
| Q4 25 | $2.2B | $1.7B | ||
| Q3 25 | $2.2B | $1.6B | ||
| Q2 25 | $2.1B | $1.6B | ||
| Q1 25 | $2.0B | $1.6B | ||
| Q4 24 | $2.2B | $1.5B | ||
| Q3 24 | $2.1B | $1.6B | ||
| Q2 24 | $2.0B | $1.5B | ||
| Q1 24 | $2.2B | $1.4B |
| Q4 25 | 0.66× | 0.70× | ||
| Q3 25 | 0.65× | 0.76× | ||
| Q2 25 | 0.70× | 0.82× | ||
| Q1 25 | 0.75× | 0.87× | ||
| Q4 24 | 0.78× | 0.98× | ||
| Q3 24 | — | 1.65× | ||
| Q2 24 | — | 1.98× | ||
| Q1 24 | — | 1.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $206.5M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $206.5M | ||
| Q3 25 | $137.3M | $57.6M | ||
| Q2 25 | $137.2M | $52.0M | ||
| Q1 25 | $-117.5M | $26.8M | ||
| Q4 24 | $133.0M | $195.7M | ||
| Q3 24 | $91.8M | $49.4M | ||
| Q2 24 | $107.0M | $62.6M | ||
| Q1 24 | $-125.2M | $14.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $195.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $62.4M | ||
| Q1 24 | — | $14.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 59.8% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 21.6% | ||
| Q1 24 | — | 5.6% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | 2.36× | ||
| Q1 25 | -5.66× | 1.46× | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | 2.17× | ||
| Q2 24 | — | — | ||
| Q1 24 | -31.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
ROOT
Segment breakdown not available.
